FDA Extends Antidepressant “Black Box” Warning On Suicidality To Young Adults
This article was originally published in The Pink Sheet Daily
Executive Summary
Updated labeling, however, also adds language about the risks of depression to emphasize that antidepressants have value.
You may also be interested in...
DTC Advertising For ADHD, Acne, Antidepressant Meds Could Shift After FDA Study
Seeking to better understand how adolescents process information in direct-to-consumer ads, agency proposes survey using web-based promotions for fictitious treatments.
FDA Panel Opposes “Boxed” Warning For Increased Suicidality In Anti-Epileptic Drugs
Committee agrees anti-epileptics demonstrate a risk signal for suicidality, but sees potential for more harm than good in adding black box.
FDA Panel Opposes “Boxed” Warning For Increased Suicidality In Anti-Epileptic Drugs
Committee agrees anti-epileptics demonstrate a risk signal for suicidality, but sees potential for more harm than good in adding black box.